Interleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targeting

Cell Proliferation

Volumn 46, Issue 4, 2013, Pages 365-373

  Kurosaka, M ^a,b   Machida, S ^a,c  

^a TOKAI UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN D1; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; MYOGENIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SATELLITE CELL; SIGNAL TRANSDUCTION;

ANIMALS; CELL GROWTH PROCESSES; CELL NUCLEUS; CYCLIN D1; INTERLEUKIN-6; JANUS KINASE 2; MALE; MYOGENIN; PHOSPHORYLATION; RATS; RATS, INBRED F344; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84880692649     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12045     Document Type: Article

References (44)

1. Mauro A (1961) Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495.
2. Hawke TJ, Garry DJ (2001) Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551.
3. Kadi F, Charifi N, Denis C, Lexell J, Andersen JL, Schjerling P et al. (2005) The behaviour of satellite cells in response to exercise: what have we learned from human studies? Pflugers Arch. 451, 319-327.
4. Ten Broek RW, Grefte S, Von den Hoff JW (2010) Regulatory factors and cell populations involved in skeletal muscle regeneration. J. Cell. Physiol. 224, 7-16.
5. Yablonka-Reuveni Z (2011) The skeletal muscle satellite cell: still young and fascinating at 50. J. Histochem. Cytochem. 59, 1041-1059.
6. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406.
7. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A et al. (1995) Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem. Biophys. Res. Commun. 207, 168-174.
8. Haddad F, Zaldivar F, Cooper DM, Adams GR (2005) IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98, 911-917.
9. Pereira LS, Narciso FM, Oliveira DM, Coelho FM, Souza Dda G, Dias RC (2009) Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Arch. Gerontol. Geriatr. 48, 313-316.
10. Baltgalvis KA, Berger FG, Peña MM, Davis JM, White JP, Carson JA (2009) Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min/+) mouse. Pflugers Arch. 457, 989-1001.
11. Al-Shanti N, Stewart CE (2012) Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3. J. Cell. Biochem. 113, 923-933.
12. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L (1997) The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 20, 815-822.
13. Spangenburg EE, Booth FW (2006) Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(-/-) mouse. Cytokine 34, 125-130.
14. Washington TA, White JP, Davis JM, Wilson LB, Lowe LL, Sato S et al. (2011) Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol. 202, 657-669.
15. Austin L, Bower J, Kurek J, Vakakis N (1992) Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J. Neurol. Sci. 112, 185-191.
16. Wang X, Wu H, Zhang Z, Liu S, Yang J, Chen X et al. (2008) Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts. Cell. Mol. Neurobiol. 28, 113-124.
17. Serrano AL, Baeza-Raja B, Perdiguero E, Jardí M, Muñoz-Cánoves P (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7, 33-44.
18. McKay BR, De Lisio M, Johnston AP, O'Reilly CE, Phillips SM, Tarnopolsky MA et al. (2009) Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS ONE 4, e6027.
19. Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G (2011) IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS One 6, e17392.
20. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314.
21. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K et al. (1998) STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 17, 6670-6677.
22. Moran DM, Mattocks MA, Cahill PA, Koniaris LG, McKillop IH (2008) Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J. Surg. Res. 147, 23-33.
23. Gao B, Wang H, Lafdil F, Feng D (2012) STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J. Hepatol. 57, 430-441.
24. Spangenburg EE, Booth FW (2002) Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am. J. Physiol. Cell Physiol. 283, C204-211.
25. Plaisance I, Morandi C, Murigande C, Brink M (2008) TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Am. J. Physiol. Endocrinol. Metab. 294, E241-250.
26. Kook SH, Choi KC, Son YO, Lee KY, Hwang IH, Lee HJ et al. (2008) Involvement of p38 MAPK-mediated signaling in the calpeptin-mediated suppression of myogenic differentiation and fusion in C2C12 cells. Mol. Cell. Biochem. 310, 85-92.
27. Machida S, Booth FW (2004) Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp. Gerontol. 39, 1521-1525.
28. Caldow MK, Steinberg GR, Cameron-Smith D (2011) Impact of SOCS3 overexpression on human skeletal muscle development in vitro. Cytokine 55, 104-109.
29. Ivashkiv LB, Hu X (2004) Signaling by STATs. Arthritis Res. Ther. 6, 159-168.
30. Wei Q, Paterson BM (2001) Regulation of MyoD function in the dividing myoblast. FEBS Lett. 490, 171-178.
31. Snyder M, Huang XY, Zhang JJ (2008) Identification of novel direct Stat3 target genes for control of growth and differentiation. J. Biol. Chem. 283, 3791-3798.
32. Spangenburg EE (2005) SOCS-3 induces myoblast differentiation. J. Biol. Chem. 280, 10749-10758.
33. Kalai M, Montero-Julian FA, Grötzinger J, Fontaine V, Vandenbussche P, Deschuyteneer R et al. (1997) Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood 89, 1319-1333.
34. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20.
35. Nakajima T, Yamamoto S, Cheng M, Yasukawa K, Hirano T, Kishimoto T et al. (1992) Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro. Jpn. J. Cancer Res. 83, 373-378.
36. Scheele C, Nielsen S, Kelly M, Broholm C, Nielsen AR, Taudorf S et al. (2012) Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One 7, e39657.
37. Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F et al. (1995) A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14, 1421-1429.
38. Ueda T, Bruchovsky N, Sadar MD (2002) Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J. Biol. Chem. 277, 7076-7085.
39. Baeza-Raja B, Muñoz-Cánoves P (2004) p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 15, 2013-2026.
40. Sun L, Ma K, Wang H, Xiao F, Gao Y, Zhang W et al. (2008) JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J. Cell Biol. 179, 129-138.
41. Wang K, Wang C, Xiao F, Wang H, Wu Z (2008) JAK2/STAT2/STAT3 are required for myogenic differentiation. J. Biol. Chem. 283, 34029-3436.
42. Torii S, Yamamoto T, Tsuchiya Y, Nishida E (2006) ERK MAP kinase in G cell cycle progression and cancer. Cancer Sci. 97, 697-702.
43. Zetser A, Gredinger E, Bengal E (1999) p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274, 5193-5200.
44. Cabane C, Englaro W, Yeow K, Ragno M, Dérijard B (2003) Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am. J. Physiol. Cell Physiol. 284, C658-666.